|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/19 | |
| A61K 31/7042 | |||
| A61P 19/06 |
| (11) | Number of the document | 2968235 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14717246.4 |
| Date of filing the European patent application | 2014-03-06 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2017-09-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/020958 |
| Date | 2014-03-06 |
| (87) | Number | WO 2014/149789 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201361786738 P | 2013-03-15 | US |
| (72) |
ROTHENBERG, Paul, US
WAYS, Douglas., K, US
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | COMBINATION OF CANAGLIFLOZIN AND PROBENECID FOR THE TREATMENT OF HYPERURICEMIA |
| COMBINATION OF CANAGLIFLOZIN AND PROBENECID FOR THE TREATMENT OF HYPERURICEMIA |